Search Within

Lisa Bodei

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (9)
  3. Review (5)
  4. Editorial (2)
  5. Book Section (1)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (29)
  2. Molecular Imaging and Therapy Service (29)
  3. Radiology, Department of (29)
  4. Sloan Kettering Institute Postdocs (29)
  5. Solid Tumor Oncology Division (29)
  6. Center for Pancreatic Cancer Research (22)

More Groups

People
  1. Diane Reidy (17)
  2. Heiko Schoder (9)
  3. Michael Morris (9)
  4. Nitya Raj (9)
  5. Joseph O'Donoghue (8)
  6. Simone Krebs (8)

More People

Years
  1. 2024 (4)
  2. 2023 (7)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (3)
  6. 2019 (3)

More Years

Publications
  1. Journal of Nuclear Medicine (8)
  2. European Journal of Nuclear Medicine and Molecular Imaging (4)
  3. Pancreas (3)
  4. Journal of Clinical Oncology (2)
  5. Clinical Cancer Research (1)
  6. Clinical Nuclear Medicine (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (8)
  2. Springer (5)
  3. Lippincott Williams & Wilkins (4)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peptide receptor radionuclide therapy during the COVID-19 pandemic: Are there any concerns?
    Correspondence

    Bodei, L.; Bergsland, E.; de Herder, W. W.; Ferone, D.; Hicks, R. J.; Hope, T. A.; Kunikowska, J.; Pavel, M.; Reidy-Lagunes, D.; Siveke, J.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • NANETS/SNMMI consensus statement on patient selection and appropriate use of (177)Lu-DOTATATE peptide receptor radionuclide therapy
    Review

    Hope, T. A.; Bodei, L.; Chan, J. A.; El-Haddad, G.; Fidelman, N.; Kunz, P. L.; Mailman, J.; Menda, Y.; Metz, D. C.; Mittra, E. S.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Is the vision of radioligand therapy for prostate cancer becoming a reality? An overview of the phase III VISION trial and its importance for the future of theranostics
    Review

    Rahbar, K.; Bodei, L.; Morris, M. J.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Biodistribution and radiation dose estimates for (68)Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
    Journal Article

    Krebs, S.; Pandit-Taskar, N.; Reidy, D.; Beattie, B. J.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; O'Donoghue, J. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with (dosimetric) (177)Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Meeting Abstract

    Krebs, S.; O'Donoghue, J.; Biegel, E.; Beattie, B. J.; Reidy, D.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
    Journal Article

    Alvarez, M. J.; Subramaniam, P. S.; Tang, L. H.; Grunn, A.; Aburi, M.; Rieckhof, G.; Komissarova, E. V.; Hagan, E. A.; Bodei, L.; Clemons, P. A.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • Theranostic trial of well differentiated neuroendocrine tumors (NETs) with 68Ga-OPS201 and 177Lu-OPS201
    Meeting Abstract

    Reidy-Lagunes, D.; Pandit-Taskar, N.; Krebs, S.; O'Donoghue, J.; Raj, N. P.; Cruz, E.; Pham, H.; Lashley, A.; Bodei, L.; Weber, W.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
    Journal Article

    Corrias, G.; Horvat, N.; Monti, S.; Basturk, O.; Lin, O.; Saba, L.; Bodei, L.; Reidy, D. L.; Mannelli, L.
    Medicine (2017)

    Fulltext@MSK | Save